cardiovascular risks of residual inflammation despite lipid-lowering | dr. paul ridker
Published 1 year ago • 824 plays • Length 8:42
Download video MP4
Download video MP3
Similar videos
-
1:01
cardiovascular risks of residual inflammation despite lipid-lowering | take away | dr. paul ridker
-
3:43
dr. paul ridker speaks on inflammation and heart disease
-
3:52
esc 2015: dose lowering inflammation lower vascular risk? paul ridker m.d
-
6:27
aha 2018: the cardiovascular inflammation reduction trial (cirt) - prof paul m ridker
-
40:53
inflammation and coronary artery disease with dr paul ridker
-
8:03
acc 23: inflammatory risk from statin-treated patients
-
10:21
surviving heart attacks: the magic of cardiac collateralization
-
25:21
your guide to heart medications: blood pressure, diuretics, and cholesterol explained | ask the doc
-
1:19:48
oxidized ldl: heart disease risk? [study 184-189 analysis]
-
20:49
dr aruna pradhan - have we reached the limits of lipid lowering? what next? - full version
-
40:21
professor peter libby - professor derick raal - inflammation vs ldl lowering
-
30:12
dr peter libby - cardiac atheroma at the limits – are we fighting the final battle?
-
5:27
ep 1 what do we really know? | cholesterol, inflammation, and cardiovascular risk
-
1:02:26
cholesterol, inflammation and heart disease webinar
-
23:06
grand rounds interview with paul m. ridker, md (january 23, 2020)
-
20:25
looking beyond ldl-c to address ascvd risk
-
1:02:51
optimizing lipid risk factors: focus on residual risk, dr. david vorchheimer
-
54:06
cardiologists perspective on fats, cholesterol and cardiovascular disease
-
2:15
dr. paul ridker, cardiovascular disease prevention video - brigham and women's hospital
-
47:07
highlights on the great debate on lipid-lowering therapies: esc 2022
-
12:20
inflammation, coronary artery disease and hs-crp with dr paul ridker
-
1:02:00
beyond ldl: assessing and treating residual ascvd risk | marc-andre cornier, md
Clip.africa.com - Privacy-policy